Kavya Parasa

Kavya Parasa practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Kavya Parasa's NPI, 1811509011, was assigned on August 19, 2020. Kavya Parasa holds Illinois license 036165025.

Kavya Parasa's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Kavya Parasa's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. The medical group on file is Rush University Internists. Dmand AI also links Kavya Parasa to 3 more home health agencies and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kavya Parasa practices, 5 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Kavya Parasa's primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dmand AI has Kavya Parasa's licenses on file in 2 states: Illinois and Texas.

CMS data shows 124 Medicare services from Kavya Parasa across 4 procedure codes in 2024, for 57 Medicare patients. Medicare paid $9,663 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 57 Medicare patients who saw Kavya Parasa in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 72% have diabetes. 51% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kavya Parasa's median patient age at 78, with 66% women.

In 2024, Kavya Parasa wrote 222 Medicare Part D claims for 63 patients. 86% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $500 in total drug cost. In 2023, CMS named 55 claims across 3 drugs.

Kavya Parasa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kavya Parasa as offering telehealth.

CMS Open Payments shows 1 general payment to Kavya Parasa from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $21.